Welcome to our dedicated page for VICOR SEC filings (Ticker: VICR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vicor Corporation filings document the operating results, governance, and security structure of a NASDAQ-listed manufacturer of modular power components and complete power systems. Form 8-K reports furnish quarterly and annual financial-results press releases under Item 2.02, with exhibits and Inline XBRL cover data tied to product revenue, royalty revenue, licensing income, and related operating commentary.
Proxy and annual meeting filings cover director elections, executive compensation, equity award tables, pay-versus-performance data, and security-holder voting matters. The filings also describe the company's common stock registered under Section 12(b), the VICR trading symbol, and charter voting rights for Common Stock and Class B Common Stock.
Vicor Corporation (VICR) insider has filed a Form 144 for a small planned stock sale. The notice covers the proposed sale of 200 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $29,976.00. The shares relate to an issuer with 32,925,914 common shares outstanding and are expected to be sold on or about January 20, 2026 on the NASDAQ.
The 200 shares to be sold were acquired on January 20, 2026 via a cash exercise of stock options. The filing also lists prior Rule 10b5-1 plan sales over the past three months by Andrew Damico, including transactions such as 14,677 shares of common stock sold on October 22, 2025 for gross proceeds of $1,211,253.00, alongside several smaller sales.
Vicor director Samuel J. Anderson exercised stock options and increased his direct shareholdings. On 01/15/2026, he exercised a non‑qualified stock option with a $100 exercise price for 800 shares of Vicor common stock, acquiring 800 shares at $100 per share.
These options were originally granted on 06/25/2021 under the company’s Amended and Restated 2000 Stock Option and Incentive Plan and vest over five years, with an expiration date of 06/25/2031. Following this transaction, Anderson directly holds 9,898 shares of Vicor common stock and 200 non‑qualified stock options.
Vicor Corp director Andrew D'Amico reported an option exercise and related share sale. On 01/15/2026 he exercised a non-qualified stock option for 200 shares of common stock at $100 per share, increasing his directly held common shares to 200 and his option holdings to 400. On the same day, he sold 200 common shares at $150 per share, leaving him with 0 shares of common stock directly owned and 400 non-qualified stock options outstanding. The sale was carried out under a Rule 10b5-1 trading plan adopted on September 12, 2024.
Vicor insider Andrew Damico has filed a Form 144 indicating an intent to sell 200 shares of Vicor common stock. The planned sale, through Morgan Stanley Smith Barney on NASDAQ, has an aggregate market value of $29,064, with 32,925,914 Vicor shares outstanding. The 200 shares were acquired the same day via a cash exercise of stock options.
The notice also lists prior Rule 10b5-1 sales by Damico over the past three months, including 14,677 shares sold on 10/22/2025 for $1,211,253 and several smaller transactions. By signing the form, the insider represents that he is not aware of any undisclosed material adverse information about Vicor.
Vicor Corporation insider Philip D. Davies, VP Global Sales & Marketing and a director, reported an option exercise and share acquisition. On January 7, 2026, he exercised 1,920 non-qualified stock options at an exercise price of $41.61 per share, receiving 1,920 shares of common stock, all held directly.
The options were originally granted on May 2, 2023 under Vicor’s Amended and Restated 2000 Stock Option and Incentive Plan, vesting over five years, and expiring two years from each vesting date. After this transaction, Davies directly holds 1,920 common shares and 17,278 stock options.
Vicor Corp director Andrew D'Amico exercised stock options for 400 shares at $100 and sold 400 common shares in two trades at $140 and $145 on January 5, 2026.
The Form 4 shows 600 stock options remaining after these transactions. The sales were carried out under a Rule 10b5-1 trading plan adopted on September 12, 2024, indicating they were pre-scheduled rather than discretionary market-timing trades.
Vicor Corp officer Alex Gusinov reported a sale of company stock. On 12/15/2025, he sold 3,844 shares of Vicor Corp common stock at a price of $97.3114 per share, coded as a sale transaction on Form 4.
Following this transaction, he directly beneficially owns 10,340 shares of Vicor Corp common stock, according to the filing.
Vicor Corp insider Michael McNamara, a director and officer serving as General Manager Mfg. Ops, reported option-related transactions in the company’s common stock dated 12/11/2025.
He exercised non-qualified stock options to acquire 2,626 shares at $69.04 and 1,611 shares at $31.05, and on the same date sold 2,626 shares at $101.1988 and 1,611 shares at $101.2805.
Following these trades, he beneficially owned 18,138 shares of Vicor common stock directly and held 10,000 non-qualified stock options exercisable at $69.04, which expire on 06/24/2030.
Vicor Corporation insider Patrizio Vinciarelli, the company’s chairman, CEO and 10% owner, reported open-market sales of common stock executed under a Rule 10b5-1 trading plan adopted on December 10, 2024. On 11/12/2025, he sold 10,000 shares at $100.1818 per share, followed by 5,724 shares at $101.1026 on 12/10/2025, and two sales on 12/11/2025 of 4,276 and 1,900 shares at $101.6477 and $102.0802 per share, respectively.
After these transactions, he beneficially owned 9,828,363 shares of Vicor common stock directly, and 171,125 shares indirectly as trustee of an irrevocable trust established for the benefit of his child.
Vicor Corporation director Jason Carlson reported a series of stock option exercises and same-day stock sales dated 12/10/2025. He exercised several non-qualified stock option grants with exercise prices ranging from $19.35 to $68.48 per share, receiving equivalent amounts of Vicor common stock.
On the same date, he sold the acquired shares in multiple transactions at a reported price of $100.2389 per share. After each reported sale, the number of directly held Vicor common shares was listed as zero, indicating no directly owned common stock at the end of these transactions.